Quantitative risk-benefit analysis of natalizumab

J. P. Thompson, K. Noyes, E. R. Dorsey, S. R. Schwid, R. G. Holloway

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Fingerprint

Dive into the research topics of 'Quantitative risk-benefit analysis of natalizumab'. Together they form a unique fingerprint.

Medicine & Life Sciences